Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Advances in Radiation Oncology
|
April 3, 2023
Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice
Maria C Cuitiño, Jessica L Fleming, Sagarika Jain, et al.
The Journal of Nutrition
|
February 26, 2019
Single Nucleotide Polymorphisms in β-Carotene Oxygenase 1 are Associated with Plasma Lycopene Responses to a Tomato-Soy Juice Intervention in Men with Prostate Cancer
Nancy E Moran, Jennifer M Thomas-Ahner, Jessica L Fleming, et al.
Oncotarget
|
January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomas
Sasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Plos One
|
March 12, 2015
A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy
Erica Hlavin Bell, Simon Kirste, Jessica L Fleming, et al.
Oncogene
|
December 19, 2018
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
Brain Pathology (Zurich, Switzerland)
|
February 24, 2023
Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease)
Aline P Becker, Diana S Osorio, Erica H Bell, et al.
Molecular Cancer Research : MCR
|
September 25, 2020
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Scientific Reports
|
August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
Karnika Singh, Chunhua Han, Jessica L Fleming, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Advances in Radiation Oncology
|
April 3, 2023
Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice
Maria C Cuitiño, Jessica L Fleming, Sagarika Jain, et al.
The Journal of Nutrition
|
February 26, 2019
Single Nucleotide Polymorphisms in β-Carotene Oxygenase 1 are Associated with Plasma Lycopene Responses to a Tomato-Soy Juice Intervention in Men with Prostate Cancer
Nancy E Moran, Jennifer M Thomas-Ahner, Jessica L Fleming, et al.
Oncotarget
|
January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomas
Sasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Plos One
|
March 12, 2015
A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy
Erica Hlavin Bell, Simon Kirste, Jessica L Fleming, et al.
Oncogene
|
December 19, 2018
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
Brain Pathology (Zurich, Switzerland)
|
February 24, 2023
Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease)
Aline P Becker, Diana S Osorio, Erica H Bell, et al.
Molecular Cancer Research : MCR
|
September 25, 2020
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma
Tiantian Cui, Erica H Bell, Joseph McElroy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Scientific Reports
|
August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
Karnika Singh, Chunhua Han, Jessica L Fleming, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Page
of 3